Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Kariminejad - |
RCV001813998 | SCV001755129 | likely pathogenic | Abnormality of the musculature | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000019067 | SCV004294368 | pathogenic | Familial infantile myasthenia | 2023-06-19 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 336 of the CHAT protein (p.Ile336Thr). This variant is present in population databases (rs121912823, gnomAD 0.006%). This missense change has been observed in individuals with congenital myasthenic syndrome (PMID: 12609506). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 17515). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CHAT protein function. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000019067 | SCV005057483 | pathogenic | Familial infantile myasthenia | 2024-03-28 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000019067 | SCV000039354 | pathogenic | Familial infantile myasthenia | 2003-05-01 | no assertion criteria provided | literature only | |
Neuromuscular Department, |
RCV000019067 | SCV001450591 | pathogenic | Familial infantile myasthenia | 2016-03-03 | no assertion criteria provided | clinical testing |